HP
BMY icon

Hyperion Partners’s Bristol-Myers Squibb BMY Stock Holding History

Hyperion Partners’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$226K Buy
+4,372
New +$205K 0.14% 67
2024
Q2 		– Sell
-4,368
Closed -$237K – 72
2024
Q1 		$237K Sell
4,368
-124
-3% -$6.32K 0.17% 57
2023
Q4 		$231K Sell
4,492
-3,964
-47% -$208K 0.18% 57
2023
Q3 		$491K Sell
8,456
-39
-0.5% -$2.39K 0.42% 31
2023
Q2 		$543K Buy
8,495
+33
+0.4% +$2.21K 0.46% 27
2023
Q1 		$587K Buy
8,462
+27
+0.3% +$1.9K 0.53% 24
2022
Q4 		$607K Buy
+8,435
New +$636K 0.58% 21

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return